Ferroptosis: past, present and future
A GLP-1 maintenance dose may involve: Staying at a mid-range dose Reducing to a lower dose Avoiding escalation once weight is stable There is no requirement to reach the maximum licensed dose to remain on treatment
This study was presented on Saturday in the Endocrine Societys annual meeting in Boston, Mass, at ENDO 2024 (1 Trusted Source GLP-1 medications for type 2 diabetes and obesity may lower risk of acute pancreatitis Go to source)
Heart Int
Since its India launch in March 2025, Mounjaro has accumulated 233 crore in total sales, capturing significant market share in the obesity and diabetes drug segment
In vitro analysis should be followed by in vivo analysis of inflammatory, metabolic and atrophic effects (using Gcs-induced osteoporosis models, skin atrophy, myopathy, etc.) [8]